348 related articles for article (PubMed ID: 16858075)
21. New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
Caldini A; Nozzoli C; Terreni A; Staderini M; Berardi M; Biagioli T; Brogi M; Bosi A
Clin Chem Lab Med; 2016 Jun; 54(6):991-5. PubMed ID: 26581069
[TBL] [Abstract][Full Text] [Related]
22. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.
Bradwell AR; Carr-Smith HD; Mead GP; Tang LX; Showell PJ; Drayson MT; Drew R
Clin Chem; 2001 Apr; 47(4):673-80. PubMed ID: 11274017
[TBL] [Abstract][Full Text] [Related]
23. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
[TBL] [Abstract][Full Text] [Related]
24. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
Jaskowski TD; Litwin CM; Hill HR
Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
[TBL] [Abstract][Full Text] [Related]
25. κ and λ urine free light chains: a new method for quantification.
Giussani M; Ciniselli CM; Macciotta A; Panella R; Verderio P; Bonini C; Morelli D
Tumori; 2020 Dec; 106(6):457-463. PubMed ID: 31955649
[TBL] [Abstract][Full Text] [Related]
26. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
27. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
[TBL] [Abstract][Full Text] [Related]
28. Serum free light chain analysis.
Davids MS; Murali MR; Kuter DJ
Am J Hematol; 2010 Oct; 85(10):787-90. PubMed ID: 20721885
[TBL] [Abstract][Full Text] [Related]
29. Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry.
Sepiashvili L; Kohlhagen MC; Snyder MR; Willrich MAV; Mills JR; Dispenzieri A; Murray DL
Clin Chem; 2019 Aug; 65(8):1015-1022. PubMed ID: 31171529
[TBL] [Abstract][Full Text] [Related]
30. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation.
Willrich MA; Ladwig PM; Andreguetto BD; Barnidge DR; Murray DL; Katzmann JA; Snyder MR
Clin Chem Lab Med; 2016 Jun; 54(6):1085-93. PubMed ID: 26812875
[TBL] [Abstract][Full Text] [Related]
32. A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female.
Fager Ferrari M; Lemonakis K; Förnvik Jonsson M
Scand J Clin Lab Invest; 2021 Sep; 81(5):385-388. PubMed ID: 34097568
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
Wolff F; Thiry C; Willems D
Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
[TBL] [Abstract][Full Text] [Related]
35. Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy.
Evliyaoglu O; van Helden J; Jaruschewski S; Imöhl M; Weiskirchen R
Clin Biochem; 2019 Dec; 74():42-46. PubMed ID: 31526775
[TBL] [Abstract][Full Text] [Related]
36. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
[TBL] [Abstract][Full Text] [Related]
37. Effects of Long-Term Storage on Serum Free Light Chain Stability.
Hörber S; Klein R; Peter A
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
[TBL] [Abstract][Full Text] [Related]
38. Studies of Bence Jones proteins by immunonephelometry.
Levinson SS
Ann Clin Lab Sci; 1992; 22(2):100-9. PubMed ID: 1562164
[TBL] [Abstract][Full Text] [Related]
39. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
Cao F; Zhang R; Xu L; Liu M; Yuan Y
Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
[TBL] [Abstract][Full Text] [Related]
40. Combined light chain immunofixation to detect monoclonal gammopathy: a comparison to standard electrophoresis in serum and urine.
Jenner W; Klingberg S; Tate JR; Wilgen U; Ungerer JP; Pretorius CJ
Clin Chem Lab Med; 2014 Jul; 52(7):981-7. PubMed ID: 24566368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
